Introduction to the disease --;Neuropathology and molecular pathogenesis of primary brain tumors --;Epidemiology of primary brain tumors --;Current therapy for primary brain tumors --;Introduction to immunotherapy of brain tumors --;Immunostimulation and immunomodulation of brain tumors --;Biological principles of brain tumor immunotherapy --;Adoptive cellular immunotherapy of brain tumors --;Systemic T-cell immunotherapy for brain tumors --;Cytotoxic T-lymphocytes reactive to patient major histocompatibility complex proteins for therapy of brain tumors --;Autologous vaccine and adoptive cellular immunotherapy as treatment for brain tumors --;Antibody-mediated immunotherapy of brain tumors --;Anti-idiotype immunotherapy strategies for brain tumors --;Radiolabeled antibodies for therapy of brain tumors --;Immunotoxin therapy of brain tumors --;Antibodies to adhesion molecules for immunotherapy of brain tumors --;Tumor vaccines and other strategies --;Cytokine-based immuno-gene therapy for brain tumors --;Downregulation of transforming growth factor [beta] as therapeutic approach for brain tumors --;Dendritic cell immunotherapy for brain tumors --;Death ligand/death receptor-mediated apoptosis for treatment of brain tumors --;Combining radiation therapy with immunotherapy for treatment of brain tumors.
SUMMARY OR ABSTRACT
Text of Note
An authoritative panel of researchers and clinicians critically reviews the entire field to provide a comprehensive guide to modern brain tumor immunotherapy and thereby enhance future research in this area.